Benzinga Logo
QQQ
–%
DIA
–%
SPY
–%
TLT
–%
GLD
–%
BTC/USD
–%
Contribute
Sign in
Benzinga Logo
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Range
5.14 - 5.34
Vol / Avg.
1.1M/1.5M
Div / Yield
-
52 Wk
4.42 - 18
Mkt Cap
397.9M
Payout Ratio
-
Open
5.3
P/E
-
EPS
-0.71
Shares
75.5M
Outstanding
75.5M
Total Float
71.7M
Benzinga - 2 days ago
Benzinga - Oct 12, 2021, 8:30AM
Benzinga - Aug 13, 2021, 7:31AM
Benzinga - Aug 6, 2021, 12:22PM
Benzinga - Aug 6, 2021, 6:07AM
Benzinga - Aug 6, 2021, 5:37AM
Benzinga - Aug 6, 2021, 5:24AM
Benzinga - Aug 6, 2021, 5:23AM
Benzinga - Aug 5, 2021, 6:31PM
Benzinga - Aug 5, 2021, 7:20AM
load more
Sector: Health Care.Industry: Biotechnology
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. Karyopharm's lead compound, XPOVIO (selinexor), is approved in the U.S. in multiple hematologic malignancy indications, including in combination with Velcade (bortezomib) and dexamethasone for the treatment of adult patients with multiple myeloma after at least one prior therapy, in combination with dexamethasone for the treatment of adult patients with heavily pretreated multiple myeloma and as a monotherapy for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma.

Earnings

see more
Q3 2021Est.ActualSurprise
EPS
(EXPECTED)2021-11-05
REV
Q2 2021Est.ActualSurprise
EPS-0.740-0.710 0.0300
REV25.640M22.601M-3.039M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Karyopharm Therapeutics Questions & Anwsers

Q

How do I buy Karyopharm Therapeutics (KPTI) stock?

A

You can purchase shares of Karyopharm Therapeutics (NASDAQ: KPTI) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Karyopharm Therapeutics's (KPTI) competitors?

Q

What is the target price for Karyopharm Therapeutics (KPTI) stock?

A

The latest price target for Karyopharm Therapeutics (NASDAQ: KPTI) was reported by Morgan Stanley on October 12, 2021. The analyst firm set a price target for 27.00 expecting KPTI to rise to within 12 months (a possible 412.33% upside). 10 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Karyopharm Therapeutics (KPTI)?

A

The stock price for Karyopharm Therapeutics (NASDAQ: KPTI) is $5.27 last updated Fri Oct 22 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does Karyopharm Therapeutics (KPTI) pay a dividend?

A

There are no upcoming dividends for Karyopharm Therapeutics.

Q

When is Karyopharm Therapeutics (NASDAQ:KPTI) reporting earnings?

A

Karyopharm Therapeutics’s $Q3 earnings are confirmed for after-market on $November 5, 2021.

Q

Is Karyopharm Therapeutics (KPTI) going to split?

A

There is no upcoming split for Karyopharm Therapeutics.

Q

What sector and industry does Karyopharm Therapeutics (KPTI) operate in?

A

Karyopharm Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.